Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms January 4, 2024
Beckley Psytech Secures $50 Million Investment from atai to Advance Short-Duration Psychedelic Therapies January 4, 2024
Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business January 3, 2024
